Characteristics, treatment patterns and outcomes of patients with small cell lung cancer—A retrospective single institution analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Characteristics, treatment patterns and outcomes of patients with small cell lung cancer—A retrospective single institution analysis

Published:2011-03 Issue:3 Volume:71 Page:363-366
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Hermes Andreas,Waschki Benjamin,Gatzemeier Ulrich,Reck Martin

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference16 articles.

1. Cancer statistics 2008;Jemal;CA Cancer J Clin,2008

2. Krebs in Deutschland: Arbeitsgem. Bevölkerungsbezogener Krebsregister in Deutschland und RKI; 2004.

3. Changing epidemiology of small cell lung cancer in the United States over the last 30 years: analysis of the Surveillance, Epidemiologic, and End Results database;Govindan;J Clin Oncol,2006

4. Prognostic factors in lung cancer;Stanley,1985

5. WHO handbook for reporting results of cancer treatment (WHO Offdet Publication No. 48);World Health Organization,1979

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-life nationwide characteristics and outcomes of small cell lung cancer over the last 20 years: Impact of immunotherapy on overall survival in a real-life setting;European Journal of Cancer;2024-10

2. Six versus four or five cycles of first‐line etoposide and platinum‐based chemotherapy combined with thoracic radiotherapy in patients with limited‐stage small‐cell lung cancer: A propensity score‐matched analysis of a prospective randomized trial;Cancer Medicine;2024-04

3. PPIs therapy has a negative impact on the clinical outcomes of advanced SCLC patients treated with PD-L1 inhibitors;BMC Pulmonary Medicine;2023-11-11

4. Treatment patterns and clinical outcomes of extensive stage small cell lung cancer (SCLC) in the real-world evidence ESME cohort before the era of immunotherapy;Respiratory Medicine and Research;2023-11

5. Long-term effectiveness and treatment sequences in patients with extensive stage small cell lung cancer receiving atezolizumab plus chemotherapy: Results of the IFCT-1905 CLINATEZO real-world study;Lung Cancer;2023-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3